De Nil SRL
1.0 FTEThe score of De Nil shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +33 % Total assets +12 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Nil's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 33,668 € | ||||
| Equity | 439,628 € | ||||
| Cash | 54,330 € | ||||
| EBITDA | 102,498 € | ||||
| Total assets | 551,344 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 05 Jun 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
- Year ended 31 Dec 2021filed on 01 Jun 2022
De Nil's financial analysis
- Solvency79.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Nil
De Nil's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0443.701.556
- VAT number
- BE0443701556
- Peppol
- Registered · 0208:0443701556 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Mar 1991
- Registered office
- 9200 Dendermonde
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
De Nil (SRL) has been based in Dendermonde since 1991, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 33,668 € and equity of 439,628 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 79.7%, above the median of its sector (44.2%).
Companies similar to De Nil
Companies in the same business, of comparable size and area, outside its group.
- Apotheek AN Leyman Retail sale of pharmaceutical products Ghent · balance sheet 551,428 €
- Pharmacie DU Roosendael Retail sale of pharmaceutical products Uccle · balance sheet 550,788 €
- Naveau-Smeets Retail sale of pharmaceutical products Lint · balance sheet 552,659 €
- VAN EYCKEN Apotheek-Optiek Retail sale of pharmaceutical products Diest · balance sheet 553,302 €
- Cassipharma Retail sale of pharmaceutical products Ghent · balance sheet 548,988 €
- Verbofar Retail sale of pharmaceutical products Deinze · balance sheet 548,560 €
- Saint-Gilles Pharma Retail sale of pharmaceutical products Liège · balance sheet 556,225 €
- Kapelle Apotheek Retail sale of pharmaceutical products Aartselaar · balance sheet 556,476 €
Frequently asked questions about De Nil
What is the revenue of De Nil?
De Nil files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De Nil?
In Belgium, the VAT number is the company number prefixed with BE: BE0443701556 for De Nil, if the company is VAT-registered. Its company number (CBE) is 0443.701.556.
Where is the registered office of De Nil?
According to the CBE register, the registered office of De Nil is in 9200 Dendermonde.
What is the equity of De Nil?
At the close of the 2025 financial year, the equity of De Nil amounts to 439,628 €, a solvency of 79.7% of total assets.
How many people work at De Nil?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages De Nil?
The register lists 1 active mandates at De Nil. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De Nil
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →